The Department of Veterans Affairs announced it secured more than $10 billion in pharmaceutical price reductions during fiscal year 2026, a record figure for the VA health system revealed Aug. 13 that expands its capacity to treat more veterans within existing budget constraints.
The savings represent accumulated discounts across the VA’s entire formulary, according to the department’s announcement. The VA purchases prescription drugs at negotiated prices significantly lower than the commercial market due to federal procurement authority.
The VA’s pharmaceutical purchasing power is rooted in a combination of statutory authorities. The Federal Supply Schedule, the 340B Drug Pricing Program, and direct negotiations with manufacturers allow the VA to obtain drugs at prices far below what Medicare, Medicaid, and private insurers typically pay.
For the roughly 9 million veterans enrolled in VA healthcare, the savings directly affect access to medications. Lower drug costs allow the VA to maintain broader formulary coverage and reduce or eliminate copayments that veterans would otherwise face.
The $10 billion figure is particularly significant as the VA health system faces growing demand from newly eligible veterans. The PACT Act, signed into law in 2022, expanded VA healthcare eligibility to millions of veterans exposed to toxic substances during military service, including burn pits in Iraq and Afghanistan. The resulting enrollment surge has strained VA resources.
The record savings also carry implications for the broader drug pricing debate. The VA’s ability to negotiate aggressively with pharmaceutical companies is frequently cited by advocates of expanding government negotiating authority to other federal health programs.
Pharmaceutical industry groups have argued that the VA’s pricing model is not directly comparable to the commercial market because the VA operates as an integrated healthcare system with a closed formulary that can exclude drugs that do not offer competitive pricing.
Veterans service organizations praised the savings as evidence of the VA’s effective stewardship of taxpayer resources.